Ionis Pharmaceuticals, Inc.

IONS Healthcare
$83.88 +$1.96 (2.39%)
Market Cap: $13.59 B
Gurus Holding
9
Popularity Rank
#563
% of Shares Held
2.55%
Net Activity (Q3 2025)
-$10.33 M

Guru Ownership Trend

Guru Analysis for Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals, Inc. (IONS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $346.47 M.

Top institutional holders include Tweedy Browne and Catherine Wood.

Notably, Tweedy Browne has expressed high conviction in this stock, allocating 16.48% of their equity portfolio to it.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $10.33 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 125.2%. Conversely, Jefferies Group reduced exposure by 54.6%.

Portfolio Manager % Portfolio Activity Shares Value Report Date
16.48% Add 0.3% 2,901,216 $189.8 M Q3 2025
0.25% Reduce -29.9% 631,215 $41.29 M Q3 2025
0.04% Add 79.8% 486,714 $31.84 M Q3 2025
0.01% New Buy 43,578 $2.85 M Q3 2025
0.01% Add 125.2% 32,152 $2.1 M Q3 2025
0.01% Add 4.4% 12,476 $816,180 Q3 2025
0.00% Reduce -54.6% 10,169 $665,256 Q3 2025
0.00% New Buy 6,815 $438,749 Q3 2025
0.00% New Buy 6,210 $406,258 Q3 2025

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$19.64 M
Total Buy Value
New Buys 3
Additions 4
-$29.97 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
3
Net Buyers
7

FAQs for Ionis Pharmaceuticals, Inc. (IONS)

Major holders include Tweedy Browne ($189.8 M), Catherine Wood ($41.29 M), Renaissance Technologies ($31.84 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 4.13 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $10.33 M, with 7 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited IONS. The total reported sell value was $29.97 M.

Yes, 3 managers opened new positions in IONS, and 4 increased their existing holdings. The total reported buy value was $19.64 M.